BioCentury

7:00 AM GMT, Jun 14, 2010
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Results

Revlimid lenalidomide: Additional Phase III data

Additional data from 370 evaluable patients in a Phase III trial showed that following induction treatment with Revlimid plus low-dose dexamethasone resulted in at least a partial

Read the full 271 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.